tiprankstipranks
Trending News
More News >

BONESUPPORT Announces CEO Transition to Drive Continued Growth

Story Highlights
  • BONESUPPORT specializes in innovative injectable bio-ceramic bone graft substitutes.
  • Emil Billbäck steps down as CEO, with Torbjörn Sköld taking over to continue growth.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
BONESUPPORT Announces CEO Transition to Drive Continued Growth

Confident Investing Starts Here:

BONESUPPORT HOLDING AB ( (SE:BONEX) ) has issued an update.

BONESUPPORT announces a leadership transition with Emil Billbäck stepping down as CEO to become a Senior Advisor, and Torbjörn Sköld taking over as CEO effective September 1, 2025. This change is expected to leverage Sköld’s extensive MedTech experience to further advance the company’s mission of transforming bone injury care through evidence-based innovation. The transition is seen as a strategic move to continue the company’s growth trajectory and maintain its position as a leader in the orthobiologics market.

More about BONESUPPORT HOLDING AB

BONESUPPORT is a leading company in the orthobiologics industry, specializing in the development and commercialization of innovative injectable bio-ceramic bone graft substitutes. These products are designed to remodel into the patient’s own bone and have the capability of eluting drugs. The company is based in Lund, Sweden, and is known for its patented technology platform, CERAMENT, with net sales amounting to SEK 899 million in 2024.

YTD Price Performance: -20.24%

Average Trading Volume: 361

Technical Sentiment Signal: Sell

Current Market Cap: $2.16B

For a thorough assessment of BONEX stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App